A detailed history of Advisor Net Financial, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisor Net Financial, Inc holds 2,237 shares of NVO stock, worth $195,446. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,237
Previous 2,304 2.91%
Holding current value
$195,446
Previous $328,000 18.9%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$119.07 - $145.42 $7,977 - $9,743
-67 Reduced 2.91%
2,237 $266,000
Q2 2024

Jul 16, 2024

SELL
$122.71 - $146.91 $35,831 - $42,897
-292 Reduced 11.25%
2,304 $328,000
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $3,165 - $4,213
31 Added 1.21%
2,596 $333,000
Q4 2023

Jan 19, 2024

SELL
$87.78 - $105.45 $16,941 - $20,351
-193 Reduced 7.0%
2,565 $265,000
Q3 2023

Oct 12, 2023

BUY
$90.94 - $199.54 $88,484 - $194,152
973 Added 54.51%
2,758 $250,000
Q2 2023

Jul 14, 2023

SELL
$155.98 - $172.65 $467 - $517
-3 Reduced 0.17%
1,785 $288,000
Q1 2023

Apr 28, 2023

SELL
$132.34 - $159.14 $926 - $1,113
-7 Reduced 0.39%
1,788 $284,000
Q4 2022

Jan 13, 2023

SELL
$102.55 - $135.33 $44,301 - $58,462
-432 Reduced 19.4%
1,795 $0
Q3 2022

Oct 04, 2022

BUY
$95.28 - $116.93 $131,010 - $160,778
1,375 Added 161.38%
2,227 $222,000
Q2 2022

Jul 07, 2022

SELL
$103.24 - $121.81 $85,379 - $100,736
-827 Reduced 49.26%
852 $95,000
Q1 2022

Apr 14, 2022

BUY
$93.1 - $112.54 $52,787 - $63,810
567 Added 50.99%
1,679 $186,000
Q4 2021

Jan 19, 2022

BUY
$95.88 - $117.08 $29,243 - $35,709
305 Added 37.79%
1,112 $125,000
Q3 2021

Oct 15, 2021

SELL
$84.42 - $106.62 $856,694 - $1.08 Million
-10,148 Reduced 92.63%
807 $77,000
Q2 2021

Jul 06, 2021

BUY
$67.66 - $84.76 $20,162 - $25,258
298 Added 2.8%
10,955 $918,000
Q1 2021

Apr 14, 2021

BUY
$67.06 - $75.82 $3,554 - $4,018
53 Added 0.5%
10,657 $718,000
Q4 2020

Feb 04, 2021

BUY
$63.89 - $73.8 $55,903 - $64,575
875 Added 8.99%
10,604 $741,000
Q3 2020

Nov 06, 2020

BUY
$63.69 - $70.22 $75,727 - $83,491
1,189 Added 13.92%
9,729 $675,000
Q2 2020

Aug 26, 2020

BUY
$58.54 - $67.94 $12,937 - $15,014
221 Added 2.66%
8,540 $559,000
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $23,740 - $31,094
480 Added 6.12%
8,319 $501,000
Q4 2019

Feb 12, 2020

SELL
$49.86 - $58.26 $14,708 - $17,186
-295 Reduced 3.63%
7,839 $454,000
Q3 2019

Oct 23, 2019

SELL
$47.54 - $53.43 $285 - $320
-6 Reduced 0.07%
8,134 $421,000
Q2 2019

Jul 15, 2019

BUY
$46.79 - $52.47 $327 - $367
7 Added 0.09%
8,140 $415,000
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $82,891 - $94,102
1,788 Added 28.18%
8,133 $425,000
Q4 2018

Feb 08, 2019

BUY
$41.54 - $47.25 $37,884 - $43,092
912 Added 16.79%
6,345 $292,000
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $13,046 - $14,295
-279 Reduced 4.88%
5,433 $256,000
Q2 2018

Jul 27, 2018

BUY
$44.29 - $50.42 $20,772 - $23,646
469 Added 8.95%
5,712 $263,000
Q1 2018

May 08, 2018

BUY
$48.49 - $58.14 $1,503 - $1,802
31 Added 0.59%
5,243 $258,000
Q4 2017

Feb 27, 2018

BUY
$47.53 - $53.73 $247,726 - $280,040
5,212
5,212 $280,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.